| Autor: |
Yoshiaki Hara, Tilo Dehne, Katja Kotsch, Petra Reinke, Martina Seifert, Meaghan Stolk, Hans-Dieter Volk, Jochen Ringe, Juliane Ladhoff, Anja Reutzel-Selke |
| Rok vydání: |
2011 |
| Předmět: |
|
| Zdroj: |
Transplant International. 24:1112-1123 |
| ISSN: |
0934-0874 |
| DOI: |
10.1111/j.1432-2277.2011.01328.x |
| Popis: |
Brain death and prolonged cold ischemia are major contributors to the poorer long-term outcome of transplants from deceased donor kidney transplants, with an even higher impact if expanded criteria donors ('marginal organs') are used. Targeting ischemia-reperfusion injury-related intragraft inflammation is an attractive concept to improve the outcome of those grafts. As mesenchymal stem cells (MSCs) express both immunomodulatory and tissue repair properties, we evaluated their therapeutic efficacy in a rat kidney transplant model of prolonged cold ischemia. The in vitro immunomodulatory capacity of bone marrow-derived rat MSCs was tested in co-cultures with rat lymph node cells. For in vivo studies, Dark Agouti rat kidneys were cold preserved and transplanted into Lewis rats. Syngeneic Lewis MSCs were administered intravenously. Transplants were harvested on day 3, and inflammation was examined by quantitative RT-PCR and histology. Similarly to MSCs from other species, rat MSCs in vitro also showed a dose-dependent immunomodulatory capacity. Most importantly, in vivo administration of MSCs reduced the intragraft gene expression of different pro-inflammatory cytokines, chemokines, and intercellular adhesion molecule-1. In addition, fewer antigen-presenting cells were recruited into the renal allograft. In conclusion, rat MSCs ameliorate inflammation induced by prolonged cold ischemia in kidney transplantation. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Plný text